These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Current aspects of the clinical effectiveness and tolerance of captopril in the treatment of cardiovascular diseases]. Ol'binskaia LI; Mokhova OV Ter Arkh; 1984; 56(11):139-42. PubMed ID: 6395426 [No Abstract] [Full Text] [Related]
10. [Captopril in the treatment of arterial hypertension. Studies of the therapeutic effectiveness and the alleged nephrotoxicity of the drug]. Bellini G; Faccini L; Battilana G; Carretta R; Rigoni A; Puppis E; Rustia R; Englaro E; Carraro M; Fabris B; Menchini U G Clin Med; 1981 Nov; 62(11):789-800. PubMed ID: 7040155 [No Abstract] [Full Text] [Related]
11. [Captopril - profile of a new antihypertensive (author's transl)]. Gross F MMW Munch Med Wochenschr; 1981 Nov; 123(47):1803-9. PubMed ID: 6796855 [TBL] [Abstract][Full Text] [Related]
12. [Treatment of essential hypertension with captopril. Possible explanation for the etiology of this disease]. Jandrić D Srp Arh Celok Lek; 1983 Apr; 111(4):475-88. PubMed ID: 6364374 [No Abstract] [Full Text] [Related]
13. Captopril. Hanna M; Fitz A J Iowa Med Soc; 1983 Oct; 73(10):415-7. PubMed ID: 6358377 [No Abstract] [Full Text] [Related]
14. [Treatment of mild and moderate arterial hypertension with low doses of captopril]. Alves Filho G; Santos TC; Carvalho OM; Guariento ME; Rizzalitti F; Rocha JC Arq Bras Cardiol; 1984 May; 42(5):377-80. PubMed ID: 6391438 [No Abstract] [Full Text] [Related]
15. [Changes in hemodynamics and sympathetic nervous system activity induced by intermediate-term treatment of essential arterial hypertension with captopril]. Fariello R; Alicandri C; Agabiti-Rosei E; Romanelli G; Beschi M; Castellano M; Montini E; Muiesan ML; Minniti P; Boni E; Zaninelli A; Geri A; Micheli P; Muiesan G Boll Soc Ital Cardiol; 1981; 26(11):1875-8. PubMed ID: 6758820 [No Abstract] [Full Text] [Related]
16. [Effect of captopril on arterial pressure, plasma renin activity and the autonomic nervous system in essential arterial hypertension with low-normal plasma renin activity]. Sturani A; Chiarini C; Degli Esposti E; Gattiani A; Masi A; Santoro A; Umile A; Zuccalà A; Zucchelli P Minerva Nefrol; 1981; 28(3):265-9. PubMed ID: 7036015 [No Abstract] [Full Text] [Related]
17. [Captopril (Capoten). A new antihypertensive agent blocking the renin-angiotensin system]. Rasmussen S; Jensen G; Giese J Ugeskr Laeger; 1983 May; 145(22):1695-9. PubMed ID: 6349075 [No Abstract] [Full Text] [Related]
18. Demonstration of a S-methyl metabolite of captopril in patients undergoing chronic captopril therapy. Drummer OH; Jarrott B; Louis WJ Clin Exp Pharmacol Physiol Suppl; 1982; 7():81-6. PubMed ID: 6754187 [TBL] [Abstract][Full Text] [Related]
19. [Antihypertensive effect of captopril in patients with mild or moderate systemic arterial hypertension]. Savioli RM; Lima EV; Estrella LA; Puppi EJ; Praxedes JN; Nassif M; Stoeber GH; Del Nero Júnior E Arq Bras Cardiol; 1984 Jan; 42(1):67-71. PubMed ID: 6378150 [No Abstract] [Full Text] [Related]
20. [Hypertensive crisis. Treatment with captopril after failure with a diuretic. Multicenter study]. Saragoça M; Ribeiro AB; Ramos OL Arq Bras Cardiol; 1982 May; 38(5):415-9. PubMed ID: 6762867 [No Abstract] [Full Text] [Related] [Next] [New Search]